- Home
- BATRK vs CPRX Comparison
BATRK vs CPRX Comparison
Compare BATRK & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATRK
- CPRX
- Stock Information
- Founded
- BATRK 1991
- CPRX 2002
- Country
- BATRK United States
- CPRX United States
- Employees
- BATRK N/A
- CPRX N/A
- Industry
- BATRK Broadcasting
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BATRK Industrials
- CPRX Health Care
- Exchange
- BATRK Nasdaq
- CPRX Nasdaq
- Market Cap
- BATRK 2.2B
- CPRX 2.5B
- IPO Year
- BATRK N/A
- CPRX 2006
- Fundamental
- Price
- BATRK $37.58
- CPRX $22.78
- Analyst Decision
- BATRK Strong Buy
- CPRX Strong Buy
- Analyst Count
- BATRK 2
- CPRX 7
- Target Price
- BATRK $53.50
- CPRX $32.86
- AVG Volume (30 Days)
- BATRK 241.7K
- CPRX 1.4M
- Earning Date
- BATRK 02-26-2025
- CPRX 02-26-2025
- Dividend Yield
- BATRK N/A
- CPRX N/A
- EPS Growth
- BATRK N/A
- CPRX 114.68
- EPS
- BATRK N/A
- CPRX 1.18
- Revenue
- BATRK $678,378,000.00
- CPRX $460,482,000.00
- Revenue This Year
- BATRK $10.38
- CPRX $23.98
- Revenue Next Year
- BATRK $5.23
- CPRX $18.27
- P/E Ratio
- BATRK N/A
- CPRX $19.33
- Revenue Growth
- BATRK 5.31
- CPRX 32.17
- 52 Week Low
- BATRK $35.81
- CPRX $13.12
- 52 Week High
- BATRK $44.43
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- BATRK 45.90
- CPRX 56.81
- Support Level
- BATRK $35.81
- CPRX $21.23
- Resistance Level
- BATRK $38.82
- CPRX $23.26
- Average True Range (ATR)
- BATRK 0.69
- CPRX 1.14
- MACD
- BATRK 0.08
- CPRX 0.20
- Stochastic Oscillator
- BATRK 58.80
- CPRX 74.85
About BATRK Atlanta Braves Holdings Inc. Series C
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include, baseball which generates key revenue, and mixed-use development.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.